Quest Diagnostics Inc FY 2025 10-K, explained in plain English
Key financials — as reported
| Total revenue | $11.0B |
| Gross margin | 33.2% |
| Operating income | $1.6B |
| Net income | $992.0M |
| Diluted EPS | $8.75 |
| Cash & equivalents | $420.0M |
| Total assets | $16.2B |
| Long-term debt | $5.7B |
Key takeaway
Quest Diagnostics reported $11.0 billion in 2025 net revenue, serving about half of U.S. physicians and hospitals and roughly one-third of the adult population annually.
🔒 4 more takeaways in the full analysis
Beneath the surface
Cash of only $420 million against $5.671 billion in long-term debt (fair value ~$5.7 billion) implies a substantial net debt position of over $5.2 billion, a leverage level not obvious from the headline cash figure alone.
🔒 3 more insights a headline reader would miss
This is the free preview. The full analysis explains every line item above and includes 7 more findings — plus insider trades, activist stakes, and 8-K events for DGX.
Read the full analysis free Free account · 5 full analyses included · no card required